Question

In: Economics

A pharmaceutical firm claims, "Our new drug, Teptouse, is currently used on a large number of...

A pharmaceutical firm claims, "Our new drug, Teptouse, is currently used on a large number of patients to collect the evidence of therapeutic effectiveness." What stage is the new drug at for the FDA approval process?

Solutions

Expert Solution

A preclinical stage is a promising operator, which includes exploiting the advances made in understanding an infection, pharmacology, software engineering, and science. Separating an illness procedure into its segments can give focusing on tranquilize improvement. Various mixes may be integrated and tried before a promising operator develops. Before attempting a clinical trial in humans is to test the drug in living animals.

The FDA requires that certain animal tests be conducted before humans are exposed to a new molecular entity. The objectives of early in vivo testing are to demonstrate the safety of the proposed medication. The aftereffects of these tests are utilized to help the IND application that is recorded with the FDA.

The IND application incorporates synthetic and assembling information, creature test comes about, including pharmacology and security information, the reason for testing another compound in people, methodologies for insurance of human volunteers, and an arrangement for clinical testing. The FDA is happy with the documentation, the stage is set for stage 1 clinical trials.


Related Solutions

A pharmaceutical firm claims, "Our new drug, Teptouse, is currently used on a large number of...
A pharmaceutical firm claims, "Our new drug, Teptouse, is currently used on a large number of patients to collect the evidence of therapeutic effectiveness." What stage is the new drug at for the FDA approval process? IND filing Phase I of clinical testing Phase II of clinical testing Phase III of clinical testing
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure (in millimeters of mercury) for nine patients before taking the new drug and 2 hours after taking the drug are shown in the table below. Is there enough evidence to support the company's claim? Let d = (blood pressure before taking new drug) − (blood pressure after taking new drug). Use a significance level of α = 0.05 for the test. Assume that the...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure (in millimeters of mercury) for nine patients before taking the new drug and 2 hours after taking the drug are shown in the table below. Using this data, find the 99% confidence interval for the true difference in blood pressure for each patient after taking the new drug. Assume that the blood pressures are normally distributed for the population of patients both before and...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure (in millimeters of mercury) for nine patients before taking the new drug and 2 hours after taking the drug are shown in the table below. Using this data, find the 99% confidence interval for the true difference in blood pressure for each patient after taking the new drug. Assume that the blood pressures are normally distributed for the population of patients both before and...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure (in millimeters of mercury) for nine patients before taking the new drug and 22 hours after taking the drug are shown in the table below. Is there enough evidence to support the company's claim? Let d=(blood pressure before taking new drug)−(blood pressure after taking new drug). Use a significance level of α=0.01 for the test. Assume that the systolic blood pressure levels are normally...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure (in millimeters of mercury) for nine patients before taking the new drug and 2 hours after taking the drug are shown in the table below. Is there enough evidence to support the company's claim? Let d=(blood pressure before taking new drug)−(blood pressure after taking new drug). Use a significance level of α=0.01 for the test. Assume that the systolic blood pressure levels are normally...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure (in millimeters of mercury) for nine patients before taking the new drug and 2 hours after taking the drug shown in the table below. Using this data, find the 95 % confidence interval for the true difference in blood pressure for each patient after taking the new drug. Assume that the blood pressures are normally distributed for the population of patients both before and...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure (in millimeters of mercury) for nine patients before taking the new drug and 2 hours after taking the drug are shown in the table below. Is there enough evidence to support the company's claim? Let d=(blood pressure before taking new drug)−(blood pressure after taking new drug). Use a significance level of α=0.05 for the test. Assume that the systolic blood pressure levels are normally...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure (in millimeters of mercury) for nine patients before taking the new drug and 2 hours after taking the drug are shown in the table below. Is there enough evidence to support the company's claim? Let d=(blood pressure before taking new drug)−(blood pressure after taking new drug)d=(blood pressure before taking new drug)−(blood pressure after taking new drug). Use a significance level of α=0.01 for the...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure (in millimeters of mercury) for nine patients before taking the new drug and 2 hours after taking the drug are shown in the table below. Is there enough evidence to support the company's claim? Let d=(blood pressure before taking new drug)−(blood pressure after taking new drug). Use a significance level of α=0.05 for the test. Assume that the systolic blood pressure levels are normally...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT